C1qL2 Activators
C1qL2 activators are a diverse group of chemical compounds that enhance the functional activity of C1qL2 through various indirect mechanisms involving different cellular signaling pathways. Forskolin elevates intracellular cAMP, which then activates protein kinase A (PKA) to phosphorylate proteins that can influence the pathways C1qL2 is involved in, particularly enhancing C1qL2's role in synaptic plasticity. Ionomycin, by increasing intracellular calcium, activates calcium-dependent signaling pathways that are crucial for synaptic formation where C1qL2 is implicated. The activation of protein kinase C (PKC) by PMA leads to phosphorylation events that can enhance C1qL2 activity, particularly in the context of synaptic transmission. Similarly, ATP, through purinergic signaling, and S1P, through sphingosine-1-phosphate receptors, initiate downstream signaling events that enhance the activity of C1qL2 in neuron-glia communication and neurite outgrowth, respectively.
Additional activators include NAD+, which influences sirtuin pathways that can indirectly enhance C1qL2 activity in cellular stress responses, and Brefeldin A, which interferes with protein trafficking and could modulate C1qL2's availability in neuronal cells. Rolipram inhibits PDE4 to raise cAMP levels, which indirectly enhances C1qL2 activity through PKA phosphorylation of relevant substrates. EGCG, by inhibiting kinases, may relieve negative regulatory influences on neuroprotective pathways involving C1qL2. Anandamide activates endocannabinoid receptors affecting neuronal functions and can thus enhance C1qL2 activity in synaptic modulation. CNO, when interacting with engineered DREADDs, initiates signaling that may influence C1qL2 activity in the nervous system. Collectively, these activators affect various biochemical pathways and cellular processes that lead to the enhanced functional activity of C1qL2, without directly increasing its expression or requiring direct binding to the protein.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly raises intracellular cAMP levels, which can lead to the activation of PKA. PKA, in turn, phosphorylates various proteins that can influence the signaling pathways that C1qL2 is a part of, enhancing the functional activity of C1qL2 by promoting its involvement in cellular adhesion processes. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin functions as a calcium ionophore, elevating intracellular calcium levels and activating calcium-dependent signaling pathways. This elevation can enhance the signaling cascade involving C1qL2, thereby enhancing its activity in the cellular processes it regulates, such as synaptic formation in neurons. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate and thereby alter the function of downstream proteins that interact with C1qL2, leading to an increase in C1qL2's activity in processes such as synaptic plasticity. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P is a bioactive lipid that activates sphingosine-1-phosphate receptors, leading to downstream signaling that can enhance the activity of C1qL2. S1P signaling is involved in processes such as neurite outgrowth and synaptic strength, which are processes that C1qL2 may be involved in. | ||||||
NAD+, Free Acid | 53-84-9 | sc-208084B sc-208084 sc-208084A sc-208084C sc-208084D sc-208084E sc-208084F | 1 g 5 g 10 g 25 g 100 g 1 kg 5 kg | $57.00 $191.00 $302.00 $450.00 $1800.00 $3570.00 $10710.00 | 4 | |
NAD+ serves as a coenzyme in redox reactions and also functions as a signaling molecule influencing various pathways, including those involving sirtuins. The enhancement of sirtuin activity can indirectly influence the signaling pathways involving C1qL2, leading to increased activity of C1qL2 in processes such as cellular stress responses and metabolism regulation. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts the Golgi apparatus and can affect protein trafficking including the trafficking of proteins that interact with or regulate C1qL2. By affecting these pathways, Brefeldin A may indirectly enhance the functional activity of C1qL2 by modulating its availability or localization within cells, particularly in neurons. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram inhibits phosphodiesterase-4 (PDE4), leading to increased cAMP levels within the cell. Enhanced cAMP levels can activate PKA, which then can phosphorylate substrates that modulate the activity of C1qL2, thereby indirectly enhancing C1qL2 activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to inhibit certain kinases, which can lead to altered activity of signaling pathways involving C1qL2. Through this inhibition, EGCG can enhance the activity of C1qL2 by reducing negative regulatory influences on the signaling pathways that C1qL2 is involved in, such as neuroprotective signaling. | ||||||